ATE197401T1 - Chinazolinon-arzneimittel sowie deren verwendung - Google Patents

Chinazolinon-arzneimittel sowie deren verwendung

Info

Publication number
ATE197401T1
ATE197401T1 AT95933731T AT95933731T ATE197401T1 AT E197401 T1 ATE197401 T1 AT E197401T1 AT 95933731 T AT95933731 T AT 95933731T AT 95933731 T AT95933731 T AT 95933731T AT E197401 T1 ATE197401 T1 AT E197401T1
Authority
AT
Austria
Prior art keywords
group
hydrogen
quinazolinone
drugs
lower alkoxy
Prior art date
Application number
AT95933731T
Other languages
English (en)
Inventor
Arnon Nagler
Shimon Slavin
Israel Vlodavsky
Mark Pines
Original Assignee
Agricultural Res Org
Hadasit Med Res Service
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agricultural Res Org, Hadasit Med Res Service filed Critical Agricultural Res Org
Application granted granted Critical
Publication of ATE197401T1 publication Critical patent/ATE197401T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epidemiology (AREA)
AT95933731T 1994-08-31 1995-08-29 Chinazolinon-arzneimittel sowie deren verwendung ATE197401T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL11083194A IL110831A (en) 1994-08-31 1994-08-31 Pharmaceutical compositions containing quinazolinone derivatives for preventing restenosis
PCT/US1995/011186 WO1996006616A1 (en) 1994-08-31 1995-08-29 Quinazolinone pharmaceuticals and use thereof

Publications (1)

Publication Number Publication Date
ATE197401T1 true ATE197401T1 (de) 2000-11-11

Family

ID=11066514

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95933731T ATE197401T1 (de) 1994-08-31 1995-08-29 Chinazolinon-arzneimittel sowie deren verwendung

Country Status (8)

Country Link
EP (1) EP0787000B1 (de)
JP (1) JPH10513149A (de)
CN (1) CN1108797C (de)
AT (1) ATE197401T1 (de)
AU (1) AU692307B2 (de)
DE (1) DE69519385T2 (de)
IL (1) IL110831A (de)
WO (1) WO1996006616A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114951A (en) * 1995-08-15 1999-08-17 Hadasit Med Res Service Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization
DE69714281T2 (de) * 1996-08-30 2003-02-27 Agricultural Res Org Intracoronarer stent der quinazolinone derivate enthält
US6028075A (en) 1997-02-11 2000-02-22 Pines; Mark Quinazolinone containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies
US6211188B1 (en) * 1997-02-11 2001-04-03 Hadasit Medical Research Services And Development Company Ltd Treatment of skin disorders
US6562829B1 (en) 1997-05-23 2003-05-13 Hadasit Medical Research Services & Development Co., Ltd. Treatment of hepatic cirrhosis
US6159488A (en) * 1997-08-14 2000-12-12 Agricultural Research Org. Ministry Of Agriculture (Gov.) Intracoronary stents containing quinazolinone derivatives
ES2255286T3 (es) * 1998-08-13 2006-06-16 HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT CO., LTD. Inhibicion de los procesos patogenicos relacionados con las lesiones del tejido.
AU3630100A (en) * 1999-03-19 2000-10-09 Parker Hughes Institute Quinazoline formulations and therapeutic use thereof
US7064114B2 (en) 1999-03-19 2006-06-20 Parker Hughes Institute Gel-microemulsion formulations
IL148246A0 (en) * 1999-09-09 2002-09-12 Hadasit Med Res Service Promotion of wound healing
US6545004B1 (en) 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
WO2003043995A1 (en) 2001-11-20 2003-05-30 Cytokinetics, Inc. Process for the racemization of chiral quinazolinones
BRPI0813355A2 (pt) 2007-06-22 2014-12-30 Arqule Inc Compostos de quinazolinona e métodos de uso dos mesmos
CN114469956B (zh) * 2022-01-29 2023-07-18 中国科学技术大学 常山酮在治疗和预防动脉粥样硬化性疾病的药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US26833A (en) * 1860-01-17 Improvement in plows
US3320124A (en) * 1964-07-20 1967-05-16 American Cyanamid Co Method for treating coccidiosis with quinazolinones
DE2934069A1 (de) * 1979-08-23 1981-03-12 Hoechst Ag, 6000 Frankfurt Mittel gegen theileriosen und seine verwendung.
DE3703789A1 (de) * 1987-02-07 1988-08-18 Hoechst Ag Coccidiozide mittel
CA2113229C (en) * 1994-01-11 1999-04-20 Mark Pines Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof

Also Published As

Publication number Publication date
DE69519385T2 (de) 2001-03-15
IL110831A (en) 1998-12-27
DE69519385D1 (de) 2000-12-14
AU692307B2 (en) 1998-06-04
CN1163566A (zh) 1997-10-29
EP0787000A1 (de) 1997-08-06
WO1996006616A1 (en) 1996-03-07
AU3626895A (en) 1996-03-22
JPH10513149A (ja) 1998-12-15
CN1108797C (zh) 2003-05-21
EP0787000B1 (de) 2000-11-08
IL110831A0 (en) 1994-11-11
EP0787000A4 (de) 1997-11-12

Similar Documents

Publication Publication Date Title
AU2003301020A1 (en) Isoquinolinone derivatives and their use as therapeutic agents
ATE197401T1 (de) Chinazolinon-arzneimittel sowie deren verwendung
MX9707453A (es) Derivados de quinazolina.
DK0749415T3 (da) Benzamidanaloger, der er nyttige som PARP(ADP-ribosyltransferase, ADPRT) DNA-reparationsenzym-inhibitorer
HUP0103386A2 (hu) Kinazolinszármazékok alkalmazása JAK 3 inhibitor hatású gyógyszerkészítmények előállítására
GB2334521A (en) Anthranilic acid derivatives as multi drug resistance modulators
ES2187473T3 (es) Triarylimidazoles.
TR199800697T2 (xx) Farmas�tik olarak aktif kinazolin bile�imleri.
UA35557C2 (uk) Похідні 1,2,4-оксадіазолілфеноксіалкілізоксазолу, що мають противірусну активність та фармацевтична композиція на їх основі
CA2280850A1 (en) Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies
GEP20053626B (en) Substituted 8-Arylquinoline Phosphodiesterase-4 Inhibitors, Pharmaceutical Composition Containing Them and Use Thereof
CA2360754A1 (en) Use of pyridazino[4,5-b]indole-1-acetamide derivatives for preparing medicines for treating diseases related to the dysfunction of peripheral benzodiazepin receptors
DE60013126D1 (de) Ophthalmische histamin-enthaltende zusammensetzungen und deren verwendung
ATE220908T1 (de) Intracoronarer stent der quinazolinone derivate enthält
PT861250E (pt) Derivados de amidina e de isotioureia como inibidores de oxido nitrico sintase
UA41350C2 (uk) Похідна морфоліну або її фармацевтично прийнятна сіль та фармацевтична композиція на її основі
DK0850062T3 (da) Anvendelse af halofuginon til fremstilling af et medikament til svækkelse af neovaskularisering og til behandling af maligne tumorer hos mennesker
TR200001941T1 (tr) TNF ve PDE-IV önleyici aktiviteye sahip heterosiklik bileşiklerin N-oksitleri.
ATE240329T1 (de) Zytotoxische pyrido(2,3,4-kl)acridinderivate, ihre herstellung und therapeutische verwendung
CA2198875A1 (en) Quinazolinone pharmaceuticals and use thereof
SE9603284D0 (sv) New compounds
DK0777471T3 (da) Inhibering af leukotrienbiosynese med urinstofderivater
PT1068199E (pt) N-ariloxietil-indoli-alquilaminas para o tratamento da depressao
HUP9904002A2 (hu) Hasnyálmirigy-gyulladás kezelésére vagy megelőzésére alkalmas, hatóanyagként diarilalkánszármazékokat tartalmazó gyógyászati készítmények
TH19066A (th) วิธีสำหรับยับยั้งการเพิ่มจำนวนเซลล์กล้ามเนื้อเรียบและภาวะการตีบของหลอดเลือด

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties